TUDCA Side Effects: Diarrhea, Doses & Safety

The short answer: diarrhea is the most commonly reported side effect of TUDCA and its close relative UDCA (ursodiol), it appears to be dose-dependent, and it usually resolves with a dose reduction. But TUDCA is a bile acid with real pharmacology, so there are situations — bile-duct obstruction, gallstones, pregnancy — where medical supervision is not optional.

What TUDCA Is (and Why It Can Upset Your Stomach)

TUDCA is the taurine-conjugated form of ursodeoxycholic acid (UDCA). The two are closely related: UDCA, sold as the prescription drug ursodiol (Actigall, Urso), is FDA-approved for dissolving cholesterol gallstones and treating primary biliary cholangitis (PBC).

That drug history is why the stomach issues are unsurprising. Bile acids are secreted into the intestine to digest fats and are normally reabsorbed in the terminal ileum (enterohepatic circulation). When you take extra bile acids as a supplement, the ileum's reabsorption capacity can be overwhelmed. The excess passes into the colon, where bile acids stimulate water and electrolyte secretion and speed up colonic motility — producing secretory diarrhea, the hallmark side effect of bile-acid therapy.

One caveat: most of TUDCA's human safety data comes from clinical trials in people with ALS, multiple sclerosis, or liver disease — not from healthy supplement users. No safety trial has been conducted specifically in healthy supplement users, so rates observed in those trials may not transfer directly to general wellness use.

Diarrhea: The Most Common Side Effect

Across both prescription UDCA and TUDCA trials, diarrhea shows up as the single most frequently reported adverse event:

• In UDCA gallstone-dissolution trials, diarrhea was the most frequent adverse event, occurring in 2–9% of patients (less frequent than with chenodeoxycholic acid therapy).
• In a retrospective ALS cohort taking TUDCA, diarrhea was the most common adverse effect (12 of 86 patients, 14.0%), mostly managed by reducing the dose or stopping; 13 patients (15.1%) reduced their dose and 7 (8.1%) discontinued due to side effects, which were described as primarily gastrointestinal and mild.
• In a progressive-MS trial (1,000 mg twice daily for four months), diarrhea was again the most common side effect in the TUDCA arm — three participants (12%) developed it, versus zero on placebo. GI-related adverse events overall occurred in 10 of 26 TUDCA recipients (38%) versus 4 of 21 (19%) on placebo. One serious adverse event (cholangitis) in the TUDCA group was deemed unlikely related to treatment.
• Ursodiol's regulatory product information lists diarrhea among the common side effects.

In short: loose stools on TUDCA are the single best-documented effect of this class of compounds, and dose reduction is the standard fix.

Dose Tiers and What to Expect at Each

Side effects of TUDCA appear to be dose-dependent. At lower doses they are rarely reported; as intake approaches and exceeds 1,000 mg/day, gastrointestinal complaints become more likely.

Notes: the 1,000–1,500 mg "gallbladder support" tier comes from the organicalt.com remedy page, not a formal medical guideline. Multi-year safety at any dose has not been systematically studied.

Other Reported Side Effects

Beyond diarrhea, all of these are less frequent and mostly observed in clinical-trial populations:

• Abdominal pain or cramping — 5.8% in the ALS retrospective cohort
• Bloating and gas — commonly cited in supplement reviews, mechanism consistent with bile-acid effects
• Nausea and mild reflux — occasional; some users find taking capsules with food helps
• Skin rash or itching — 3.5% in the ALS cohort; facial rash noted in one MS-trial participant
• Headache — listed in ursodiol postmarketing reports, but it was no more common than placebo in the Actigall gallstone trials (18.1% vs. 21.4%) and was not prominent in TUDCA trials
• Metallic or bitter taste — listed in ursodiol patient guidance as an occasional transient effect

Effects like fatigue, hair thinning, or back pain appear in prescription ursodiol documentation (hair loss and back pain are listed as common side effects; dizziness, malaise, and muscle pain appear in postmarketing reports), but are rarely discussed for TUDCA supplements — whether they transfer to low-dose TUDCA supplement use is unknown.

The Serious Risk: Gallstone Mobilization

This is the side effect that deserves the most respect. TUDCA promotes bile flow, and as stones shrink they can become small enough to enter the cystic duct but large enough to get stuck — potentially causing biliary colic, acute cholecystitis, or pancreatitis. This risk is inherent to the dissolution process itself, not a direct toxicity of the compound.

The emergency scenario: if a mobilized stone blocks the bile duct — signaled by sudden severe upper-abdominal pain, fever, and jaundice — that needs urgent medical care. Prescription ursodiol labeling lists complete biliary-tract obstruction as a contraindication: a hard stop, not a caution.

If you have known gallstones and are considering TUDCA, see a gastroenterologist first.

Who Should Avoid TUDCA

TUDCA is a bile acid with real pharmacology, so some situations are firm no-go's — and remember, TUDCA as a supplement is unregulated (no pre-market FDA approval, no mandated quality control), so the usual supplement cautions apply doubly:

• Bile-duct obstruction or suspected blockage. Complete biliary-tract obstruction is a contraindication for ursodiol, and the same logic applies to TUDCA. Do not take without medical supervision if you have any history of biliary obstruction.
• Known gallstones, especially symptomatic ones. Mobilization risk (see above). Practitioner guidance is essential.
• Pregnancy and breastfeeding. No published human safety study of TUDCA in pregnancy exists. Ursodiol's prescribing information states the possibility of fetal harm cannot be ruled out and the drug is not recommended in pregnancy; breastfeeding data are limited to a small number of cases. Avoid unless a clinician specifically approves.
• Liver disease. Anyone with diagnosed liver or biliary disease should only use TUDCA under a physician's care — bile-acid therapy in the wrong setting can backfire: in a randomized trial, high-dose ursodiol (28–30 mg/kg/day) in primary sclerosing cholangitis increased serious adverse events versus placebo, and the trial was stopped early.
• Upcoming surgery. A targeted literature search found no standard perioperative guidance for TUDCA regarding anesthesia or bleeding risk; discuss with your surgical team if you take it regularly.

Drug Interactions to Know

TUDCA-specific interaction studies have not been published; the following are documented for UDCA/ursodiol and are presumed to apply until proven otherwise:

• Bile-acid sequestrants (e.g., cholestyramine) and antacids can reduce UDCA absorption — taking them together may blunt the effect.
• Cyclosporine: bile-acid salts may increase the bioavailability of oral cyclosporine, though data are conflicting and the clinical significance is unknown — which matters for transplant patients.

If you take any prescription medication, run TUDCA past your pharmacist or prescriber before combining — the evidence base for interactions is thinner than it looks.

How to Minimize Side Effects

These are practical, low-risk strategies consistent with how the compound behaves in trials:

1. Start low. Begin at the 250–500 mg tier for a week or two before considering more.
2. Take it with meals. This matches the organicalt.com page's guidance and how bile acids are naturally secreted during digestion.
3. Increase gradually. Trial participants who tolerated higher doses titrated up; those who started high were more likely to need dose reductions.
4. Reduce at the first sign of diarrhea. In clinical cohorts, most GI side effects resolved with a lower dose — lowering the dose is faster than waiting it out.
5. Don't exceed 3,000 mg/day. Per the organicalt.com page's excess threshold, this is where diarrhea and GI upset become the expected outcome. Nothing in the trial literature supports routine use above 2,000 mg/day.
6. Buy from brands with third-party testing. TUDCA is an unregulated supplement, and independent testing has repeatedly found products can differ from label claims. That's a quality issue, not a TUDCA toxicity issue — but it matters when dosing an active compound.

When to Call a Doctor

Stop TUDCA and seek medical advice promptly if you experience:

• Diarrhea that persists more than a few days after reducing the dose, or that causes dehydration (dizziness, very dark urine, rapid heartbeat)
• Severe or sudden upper-right abdominal pain, especially with fever — possible biliary colic or cholecystitis
• Jaundice (yellowing of skin or eyes), dark urine, or pale/clay-colored stools
• Persistent nausea or vomiting that prevents you from keeping food or fluids down
• Signs of an allergic reaction: hives, swelling of the face or lips, difficulty breathing

These are the same red flags listed in prescription ursodiol patient guidance.

📢 Disclaimer: This information is for educational purposes only and is not medical advice. Always consult a qualified healthcare professional before starting any new supplement. Sources are linked for verification.

Explore the Full Remedy Database

Browse 500+ organic alternatives for health, wellness, and natural living.